Cellular Carcinogenesis: Role of Polarized Macrophages in Cancer Initiation

Simple Summary Inflammation is a hallmark of many cancers. Macrophages are key participants in innate immunity and important drivers of inflammation. When chronically polarized beyond normal homeostatic responses to infection, injury, or aging, macrophages can express several pro-carcinogenic phenotypes. In this review, evidence supporting polarized macrophages as endogenous sources of carcinogenesis is discussed. In addition, the depletion or modulation of macrophages by small molecule inhibitors and probiotics are reviewed as emerging strategies in cancer prevention. Inflammation is an essential hallmark of cancer. Macrophages are key innate immune effector cells in chronic inflammation, parainflammation, and inflammaging. Parainflammation is a form of subclinical inflammation associated with a persistent DNA damage response. Inflammaging represents low-grade inflammation due to the dysregulation of innate and adaptive immune responses that occur with aging. Whether induced by infection, injury, or aging, immune dysregulation and chronic macrophage polarization contributes to cancer initiation through the production of proinflammatory chemokines/cytokines and genotoxins and by modulating immune surveillance. This review presents pre-clinical and clinical evidence for polarized macrophages as endogenous cellular carcinogens in the context of chronic inflammation, parainflammation, and inflammaging. Emerging strategies for cancer prevention, including small molecule inhibitors and probiotic approaches, that target macrophage function and phenotype are also discussed.

Automated summary

Inflammation is a key characteristic of cancer, and macrophages play a crucial role in chronic inflammation, parainflammation, and inflammaging. Regardless of whether it is induced by infection, injury, or aging, immune dysregulation and chronic macrophage polarization contribute to cancer initiation by producing proinflammatory chemokines/cytokines and genotoxins, and by modulating immune surveillance. This review presents both pre-clinical and clinical evidence supporting polarized macrophages as endogenous cellular carcinogens in the context of chronic inflammation, parainflammation, and inflammaging. Additionally, emerging strategies for cancer prevention targeting macrophage function and phenotype, such as small molecule inhibitors and probiotic approaches, are discussed.